UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI MM14

Design of Molecular Proficiency Testing/ External Quality Assessment; Approved Guideline

active, Most Current
Buy Now
Organization: CLSI
Publication Date: 1 May 2013
Status: active
Page Count: 84
scope:

The purpose of this guideline is to complement currently available regulatory and guidance documents regarding the management and operations of proficiency testing/external quality assessment (PT/EQA) programs. Presently, these documents guide the administration of such programs, but consideration of panel selection, analysis of data for evolving technologies and tests with many possible measurands, method-based PT/EQA, and reporting to participants are not addressed. For molecular methods, these issues are important for all stakeholders, including regulatory agencies, accrediting agencies, PT/EQA providers/organizations, PT/EQA materials manufacturers, medical (clinical) laboratories, and test/reagent manufacturers. This document addresses both large formal PT/EQA programs as well as medical laboratorians who produce, distribute, and administer PT/EQA schemes, and should provide guidance for the development and implementation of new PT/EQA programs for nucleic acid testing or modifying existing schemes.

This guideline does not address the process of testing and reporting PT/EQA in the medical laboratory, medical laboratory inspection, accreditation, or other regulatory processes.

This guideline focuses on nucleic acid (DNA and RNA) PT in the areas of human genetics, infectious disease, molecular oncology, and pharmacogenetics. Though written specifically to address needs in this area, the principles stated may be applicable to programs outside of nucleic acid testing.

Organizations and programs that send blinded samples to laboratories and analyze the submitted results carry several different names. These challenge programs may be called PT/EQA, quality assessment or assurance programs, QC programs, ring trials, sample exchange, and EQA/assurance. Countries or regions may place regulatory distinctions on these names. To facilitate the readability of this document, the terms PT/EQA, PT/EQA provider/organization, and PT/EQA program have been chosen to describe such activities, and regulatory categorization is not implied unless specifically noted.

Document History

CLSI MM14
May 1, 2013
Design of Molecular Proficiency Testing/ External Quality Assessment; Approved Guideline
The purpose of this guideline is to complement currently available regulatory and guidance documents regarding the management and operations of proficiency testing/external quality assessment...
May 1, 2013
Design of Molecular Proficiency Testing/ External Quality Assessment; Approved Guideline
The purpose of this guideline is to complement currently available regulatory and guidance documents regarding the management and operations of proficiency testing/external quality assessment...
August 1, 2005
Proficiency Testing (External Quality Assessment) for Molecular Methods; Approved Guideline
The purpose of this guideline is to complement currently available regulatory and guidance documents regarding the management and operations of proficiency testing programs. Presently, these...

References

Advertisement